172 related articles for article (PubMed ID: 3337337)
1. Prognostic implications of the tall cell variant of papillary thyroid carcinoma.
Johnson TL; Lloyd RV; Thompson NW; Beierwaltes WH; Sisson JC
Am J Surg Pathol; 1988 Jan; 12(1):22-7. PubMed ID: 3337337
[TBL] [Abstract][Full Text] [Related]
2. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid.
Ostrowski ML; Merino MJ
Am J Surg Pathol; 1996 Aug; 20(8):964-74. PubMed ID: 8712296
[TBL] [Abstract][Full Text] [Related]
3. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
[TBL] [Abstract][Full Text] [Related]
4. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
5. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
6. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
7. Tall cell papillary thyroid cancer: incidence and prognosis.
Terry JH; St John SA; Karkowski FJ; Suarez JR; Yassa NH; Platica CD; Marti JR
Am J Surg; 1994 Nov; 168(5):459-61. PubMed ID: 7977973
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid carcinoma tall cell variant.
Ghossein R; Livolsi VA
Thyroid; 2008 Nov; 18(11):1179-81. PubMed ID: 18925842
[TBL] [Abstract][Full Text] [Related]
10. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
[TBL] [Abstract][Full Text] [Related]
12. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
[TBL] [Abstract][Full Text] [Related]
13. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms.
Filie AC; Chiesa A; Bryant BR; Merino MJ; Sobel ME; Abati A
Cancer; 1999 Aug; 87(4):238-42. PubMed ID: 10455213
[TBL] [Abstract][Full Text] [Related]
14. Tall cell variant: an aggressive form of papillary thyroid carcinoma.
Prendiville S; Burman KD; Ringel MD; Shmookler BM; Deeb ZE; Wolfe K; Azumi N; Wartofsky L; Sessions RB
Otolaryngol Head Neck Surg; 2000 Mar; 122(3):352-7. PubMed ID: 10699809
[TBL] [Abstract][Full Text] [Related]
15. Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.
Russo M; Malandrino P; Moleti M; Vermiglio F; Violi MA; Marturano I; Minaldi E; Vigneri R; Pellegriti G; Regalbuto C
J Endocrinol Invest; 2017 Nov; 40(11):1235-1241. PubMed ID: 28528434
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
[TBL] [Abstract][Full Text] [Related]
17. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.
Morris LG; Shaha AR; Tuttle RM; Sikora AG; Ganly I
Thyroid; 2010 Feb; 20(2):153-8. PubMed ID: 20151822
[TBL] [Abstract][Full Text] [Related]
18. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of tall cells in papillary thyroid carcinoma: A case-control study.
Stenman S; Siironen P; Mustonen H; Lundin J; Haglund C; Arola J
Tumour Biol; 2018 Jul; 40(7):1010428318787720. PubMed ID: 30010512
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens.
Solomon A; Gupta PK; LiVolsi VA; Baloch ZW
Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]